Cargando…
Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease
Metabolic-associated fatty liver disease (MAFLD), which is often linked to obesity, encompasses a large spectrum of hepatic lesions, including simple fatty liver, steatohepatitis, cirrhosis and hepatocellular carcinoma. Besides nutritional and genetic factors, different xenobiotics such as pharmaceu...
Autores principales: | Massart, Julie, Begriche, Karima, Corlu, Anne, Fromenty, Bernard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834714/ https://www.ncbi.nlm.nih.gov/pubmed/35162986 http://dx.doi.org/10.3390/ijms23031062 |
Ejemplares similares
-
Role of nonalcoholic fatty liver disease as risk factor for drug-induced hepatotoxicity
por: Massart, Julie, et al.
Publicado: (2017) -
Acetaminophen-Induced Hepatotoxicity in Obesity and Nonalcoholic Fatty Liver Disease: A Critical Review
por: Begriche, Karima, et al.
Publicado: (2023) -
Role of Mitochondrial Cytochrome P450 2E1 in Healthy and Diseased Liver
por: Massart, Julie, et al.
Publicado: (2022) -
Drug-induced hepatic steatosis in absence of severe mitochondrial dysfunction in HepaRG cells: proof of multiple mechanism-based toxicity
por: Allard, Julien, et al.
Publicado: (2020) -
Treatments in Covid-19 patients with pre-existing metabolic dysfunction-associated fatty liver disease: A potential threat for drug-induced liver injury?
por: Ferron, Pierre-Jean, et al.
Publicado: (2020)